Target intelligence / Profile preview

Long intergenic non-protein coding RNA 881 (LINC00881)

Target
LINC00881
Molecular classification
Other (long non-coding RNA; lncRNA)
01

Overview

Long intergenic non-protein coding RNA 881 (LINC00881), also called LIPTER (Lipid-Droplet Transporter), is a human-specific long non-coding RNA highly and specifically expressed in cardiomyocytes[2][1]. LIPTER plays a critical role in the intracellular transport of lipid droplets by directly binding with two phospholipids (phosphatidic acid and phosphatidylinositol 4-phosphate) on the surface of lipid droplets and with the myosin heavy chain 10 (MYH10) motor protein, thus connecting lipid droplets to the cytoskeleton for effective movement within cardiomyocytes[2][1]. Loss of LIPTER impairs lipid droplet trafficking, disrupts mitochondrial function, and compromises cell viability; overexpression preserves cardiac function and alleviates cardiac steatosis and cardiomyopathy in preclinical models of obesity and diabetes, pointing to its significance in heart disease associated with metabolic syndrome[2][1]. LINC00881 is not currently a direct therapeutic target in the sense of a druggable receptor, enzyme, or transporter; it is an RNA mediator of intracellular lipid dynamics relevant to heart disease biology[2][1][3].

Other names
LIPTERLipid-Droplet TransporterLINC00881
02

Biological functions

Intracellular lipid droplet transportLipid metabolism regulation in cardiomyocytesMaintenance of mitochondrial and cardiomyocyte function, especially under metabolic stress
03

Disease associations

Cardiovascular disease (especially metabolic disorder-associated heart disease and cardiomyopathy)Possibly metabolic syndrome
04

Safety considerations

No specific drug or safety data; relevant concern may be off-target effects if modulating an RNA for therapy

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 881 (LINC00881).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 881 (LINC00881).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call